Install
News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals
- 37articles · 30d
- 9+ hour agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 132avg words
- Medical 32
- Health & Wellness 28
- Health 26
- Business & Industrial 9
- Economy, Business & Finance 4
- Finance & Business 4
- Science & Technology 4
- Human Interest 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Noxopharm moves lupus skin therapy toward next human trial
9+ hour, 22+ min ago (117+ words) PharmaDispatch Noxopharm moves lupus skin therapy toward next human trial Noxopharm announced that its lead experimental therapy, SOF-SKN, will advance to an extension clinical study in patients with cutaneous lupus erythematosus, a painful, disfiguring skin condition for which no targeted…...
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
10+ hour, 22+ min ago (137+ words) PharmaDispatch Diabetes and cancer blood tests reach WA and NT patients under new Healius deal Perth-based medical technology company Proteomics International has begun selling two of its diagnostic blood tests directly to patients in Western Australia and the Northern Territory,…...
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
10+ hour, 12+ min ago (124+ words) PharmaDispatch FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making it the first FDA-sanctioned imaging agent for glioma, the…...
Melbourne oncologist takes the reins at Australia's private cancer physicians body
4+ day, 17+ hour ago (154+ words) PharmaDispatch Melbourne oncologist takes the reins at Australia's private cancer physicians body After twelve years steering the Private Cancer Physicians of Australia through some of the most consequential fights in Australian cancer policy, Christopher Steer has handed the presidency to…...
A review recommendation that should be reconsidered because of time
6+ day, 23+ hour ago (138+ words) PharmaDispatch A review recommendation that should be reconsidered because of time A plan built around expanding the traditional evaluator pipeline, without first testing what AI can absorb, risks locking in permanent headcount and cost against a workload that may shrink…...
Alterity secures option underwriting as it prepares for pivotal MSA trial
2+ week, 12+ hour ago (140+ words) PharmaDispatch Alterity secures option underwriting as it prepares for pivotal MSA trial Alterity Therapeutics has secured an underwriting agreement that could provide at least $4.2 million in additional funding as the company prepares to begin its planned Phase 3 clinical trial of…...
Noxopharm pushes Sofra platform towards cancer proof of concept
2+ week, 4+ day ago (133+ words) PharmaDispatch Noxopharm pushes Sofra platform towards cancer proof of concept Noxopharm says new laboratory findings strengthen the case for using its Sofra technology to help the immune system recognise cancer cells after treatments such as chemotherapy or radiotherapy kill them....
Insurers warn cut could hit Australians most likely to need cancer care
2+ week, 6+ day ago (124+ words) PharmaDispatch Insurers warn cut could hit Australians most likely to need cancer care The organisation has pointed to the potential impact on cancer treatment and care, highlighting that the policyholders impacted by the reduction are more likely than any other…...
Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma - BioPharmaDispatch
3+ week, 3+ day ago (135+ words) Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma PharmaDispatch Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma Professor Georgina Long, the study's principal investigator and medical director of Melanoma Institute Australia, said the findings could signal…...
New Zealand researchers honoured for work tackling superbugs and blood cancer
3+ week, 4+ day ago (138+ words) PharmaDispatch New Zealand researchers honoured for work tackling superbugs and blood cancer Two New Zealand scientists working at very different points of the medicines-development pipeline will be recognised tonight at Medicines New Zealand’s 2026 Value of Medicines Awards. … Opportunity #1 - biosimilar policy…...